Patents by Inventor Mira Toister-Achituv

Mira Toister-Achituv has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11513120
    Abstract: The present invention relates to nucleic acid molecules comprising a nucleic acid sequence encoding a membrane-bound biotin mimetic peptide (BMP) or biotin acceptor peptide (BAP). The invention also relates to a method for selection of high producer cells secreting a protein of interest.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: November 29, 2022
    Assignee: MERCK SERONO S.A
    Inventors: Daniel Helman, Mira Toister-Achituv, Meirav Bar-Shimon, Moshe Smolarsky
  • Patent number: 10676733
    Abstract: The present invention provides methods for the non-covalent surface display of proteins of interest (POI), in particular for Fc-domain containing proteins such as antibodies. The inventive method may be used to screen and select proteins of interest of a desired phenotype. The present invention further discloses polynucleotides and proteins and methods of producing the same, which may be used in carrying out the inventive method.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: June 9, 2020
    Assignee: Merck Patent GmbH
    Inventors: Laura Rhiel, Stefan Becker, Ralf Guenther, Bjoern Hock, Daniel Helman, Mira Toister-Achituv, Simon Krah
  • Publication number: 20180328925
    Abstract: The present invention relates to nucleic acid molecules comprising a nucleic acid sequence encoding a membrane-bound biotin mimetic peptide (BMP) or biotin acceptor peptide (BAP). The invention also relates to a method for selection of high producer cells secreting a protein of interest.
    Type: Application
    Filed: May 10, 2018
    Publication date: November 15, 2018
    Inventors: Daniel HELMAN, Mira TOISTER-ACHITUV, Meirav BAR-SHIMON, Moshe SMOLARSKY
  • Publication number: 20180298374
    Abstract: The present invention provides methods for the non-covalent surface display of proteins of interest (POI), in particular for Fc-domain containing proteins such as antibodies. The inventive method may be used to screen and select proteins of interest of a desired phenotype. The present invention further discloses polynucleotides and proteins and methods of producing the same, which may be used in carrying out the inventive method.
    Type: Application
    Filed: October 27, 2015
    Publication date: October 18, 2018
    Applicant: Merck Patent GmbH
    Inventors: Laura Rhiel, Stefan Becker, Ralf Guenther, Bjoern Hock, Daniel Helman, Mira Toister-Achituv, Simon Krah
  • Patent number: 9574003
    Abstract: A method of selecting cells having zero fucose level useful as host cells for expressing recombinant proteins is disclosed. The method comprises: (d) introducing genetic mutations into a population of CHO cells by contacting the cells with a methotrexate (MTX), (e) contacting the population of CHO cells comprising mutated cells with a non-toxic fucose binding agent for an amount of time that allows binding of the fucose binding agent to a fucose moiety on a cell membrane of the population of cells, wherein the amount of time does not allow killing of the cells; and (f) depleting from the population of cells comprising mutated cells, a subpopulation of cells which bind the fucose binding agent, thereby selecting cells useful as host cells for expressing recombinant proteins, the selected cells having zero fucose content. There are also disclosed cells and cell lines useful as host cells for expressing recombinant proteins.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: February 21, 2017
    Assignee: Merck Serono S.A.
    Inventors: Daniel Helman, Meirav Barshimon, Mira Toister-Achituv
  • Publication number: 20140011213
    Abstract: The present invention relates to nucleic acid molecules comprising a nucleic acid sequence encoding a membrane-bound biotin mimetic peptide (BMP) or biotin acceptor peptide (BAP). The invention also relates to a method for selection of high producer cells secreting a protein of interest.
    Type: Application
    Filed: December 19, 2011
    Publication date: January 9, 2014
    Applicant: MERCK SERONO S.A.
    Inventors: Daniel Helman, Mira Toister-Achituv, Meirav Bar-Shimon, Moshe Smolarsky
  • Publication number: 20140005368
    Abstract: A method of selecting cells having zero fucose level useful as host cells for expressing recombinant proteins is disclosed. The method comprises: (d) introducing genetic mutations into a population of CHO cells by contacting the cells with a methotrexate (MTX), (e) contacting the population of CHO cells comprising mutated cells with a non-toxic fucose binding agent for an amount of time that allows binding of the fucose binding agent to a fucose moiety on a cell membrane of the population of cells, wherein the amount of time does not allow killing of the cells; and (f) depleting from the population of cells comprising mutated cells, a subpopulation of cells which bind the fucose binding agent, thereby selecting cells useful as host cells for expressing recombinant proteins, the selected cells having zero fucose content. There are also disclosed cells and cell lines useful as host cells for expressing recombinant proteins.
    Type: Application
    Filed: March 5, 2012
    Publication date: January 2, 2014
    Applicant: Merck Serono S.A.
    Inventors: Daniel Helman, Meirav Barshimon, Mira Toister-Achituv